Form D · Other Technology
Medical Realities, Inc.
London, X0 · CIK 0001998240
Offering snapshot reported Feb 15, 2024 · SEC filing
- Reported sold
- $475K Offering amount: $1M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Aug 14, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 15, 2024 | Initial | $475,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $33.3K
- Finders' fees
- $0
- Form D file number
- 021-505379
Boustead Securities, LLC also received non-accountable expense allowance of $4,750, will receive 5-yr warrant to purchase 33,250 Class B Ordinary Shares, exercisable on a cashless basis, at exercise price of $1.00 per share, subject to adjustment.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Boustead Securities, LLC | 141391 |
Source: Form D, filed Feb 15, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Shafi Ahmed | Executive |
| Stephen Dann | Director, Executive |
| Keith Charles Moore | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
25 Cabot Square
London, X0, E14 4QZ
London, X0, E14 4QZ